Page last updated: 2024-08-22

1,3-dimethylol-5,5-dimethylhydantoin and Dermatitis, Atopic

1,3-dimethylol-5,5-dimethylhydantoin has been researched along with Dermatitis, Atopic in 1 studies

*Dermatitis, Atopic: A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema. [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Belsito, DV; Malajian, D; Shaughnessy, CN1

Other Studies

1 other study(ies) available for 1,3-dimethylol-5,5-dimethylhydantoin and Dermatitis, Atopic

ArticleYear
Cutaneous delayed-type hypersensitivity in patients with atopic dermatitis: reactivity to topical preservatives.
    Journal of the American Academy of Dermatology, 2014, Volume: 70, Issue:1

    Topics: Dermatitis, Allergic Contact; Dermatitis, Atopic; Dermatologic Agents; Female; Humans; Hydantoins; Incidence; Male; Methenamine; Patch Tests; Preservatives, Pharmaceutical; Propylene Glycols; Sex Factors; Urea

2014